Clinical Guides
Ankylosing Spondylitis
A clinically focused guide to recognising and managing ankylosing spondylitis within the axial spondyloarthritis spectrum in India, including imaging pitfalls, extra-musculoskeletal disease and biologic-treatment safeguards.
MedNext Academy | 13 min read
Ankylosing Spondylitis
A clinically focused guide to recognising and managing ankylosing spondylitis within the axial spondyloarthritis spectrum in India, including imaging pitfalls, extra-musculoskeletal disease and biologic-treatment safeguards.
Summary
Ankylosing spondylitis is the traditional name for radiographic axial spondyloarthritis, a chronic inflammatory disease in which sacroiliac-joint damage is visible on plain radiography. Axial spondyloarthritis also includes non-radiographic disease, where a compatible clinical syndrome may exist without definite radiographic sacroiliitis. The terms describe a spectrum rather than two inevitably sequential stages. Inflammation principally affects the sacroiliac joints and spine, but peripheral arthritis, enthesitis, dactylitis, acute anterior uveitis, psoriasis and inflammatory bowel disease may shape presentation and treatment.
Typical symptoms begin before age 45 and include persistent back or buttock pain, morning stiffness, night waking and improvement with movement rather than rest. None is diagnostic alone. HLA-B27 supports probability in the correct context but is neither necessary nor sufficient. Normal inflammatory markers do not exclude disease, and a normal pelvic radiograph does not end evaluation when clinical suspicion remains. MRI can demonstrate inflammatory sacroiliac lesions, but mechanical stress, postpartum change and other conditions can mimic them; image interpretation must be joined to the history and examination.
Management combines education, regular exercise and specialist physiotherapy with medicines selected for active symptoms and objective inflammation. Non-steroidal anti-inflammatory drugs are usual first pharmacological treatment when safe. Persistent active disease may justify tumour necrosis factor, interleukin-17 or Janus kinase pathway treatment after diagnostic confirmation and infection screening. This reviewed draft has been reviewed by the MedNext Clinical Team and does not authorize imaging interpretation, biologic initiation or substitution for local rheumatology protocols.
How Common Is It?
Axial spondyloarthritis occurs internationally, but prevalence varies with ancestry, HLA-B27 frequency, age structure, classification method, radiography access and recognition in primary care. Ankylosing spondylitis is less common than nonspecific mechanical low-back pain, yet delayed diagnosis creates disproportionate disability during education and working life. Symptoms often start in adolescence or early adulthood. Men have historically been diagnosed more often with radiographic disease, but women and people without classic radiographic change are under-recognised and may experience comparable symptom burden.
Published estimates are difficult to compare because some count only radiographic ankylosing spondylitis, while others include the whole axial spectrum. Hospital cohorts select for severe disease and cannot provide population prevalence. HLA-B27 frequency varies substantially and should not be converted directly into disease prevalence because most carriers never develop axial spondyloarthritis. Likewise, a family history increases clinical suspicion without predicting an individual's course.
India lacks a single continuously updated national registry that captures axial disease across states, rural and urban services and public and private care. Local audits should state diagnostic definitions and measure time from symptom onset to referral, access to MRI and physiotherapy, tuberculosis screening, extra-musculoskeletal manifestations, treatment persistence, function and work participation. For the individual patient, the important epidemiological lesson is diagnostic openness: young-onset inflammatory-pattern back pain deserves structured assessment even in a woman, an HLA-B27-negative person or someone with normal C-reactive protein.
Risk Factors
HLA-B27 is the strongest recognized genetic association, but it is a susceptibility marker rather than a diagnostic result. Risk also reflects other genes, immune pathways, microbial and environmental influences that are not reducible to a single exposure. A first-degree relative with axial spondyloarthritis, psoriasis, inflammatory bowel disease or recurrent acute anterior uveitis increases pre-test probability. Previous peripheral arthritis, heel enthesitis or dactylitis may precede prominent spinal symptoms. Age at onset below 45 is characteristic, though diagnosis may occur much later.
Smoking is associated with worse symptoms and radiographic progression and should be addressed without blaming the patient. Higher inflammatory activity, existing syndesmophytes, elevated inflammatory markers and persistent mechanical loading may identify greater structural-progression risk, but prediction remains imperfect. Obesity and poor physical conditioning can worsen function and complicate assessment. Repeated spinal trauma is not the primary cause, yet a rigid ankylosed spine is vulnerable to unstable fracture after relatively minor injury. Osteoporosis can coexist even in younger adults.
Treatment risk modifies the care plan. NSAID toxicity is more likely with renal disease, peptic ulcer, anticoagulation, uncontrolled hypertension or selected cardiovascular conditions. Biologic and targeted synthetic therapies increase particular infection risks and require tuberculosis and hepatitis assessment, vaccination review and pregnancy discussion. In India, previous tuberculosis, household exposure, residence in congregate settings and incomplete treatment history are important, but neither a positive screening assay nor an old scar proves active disease. Risk factors guide testing, referral and monitoring; they never replace clinical diagnosis.
Diagnosis
History
Clarify age at onset and duration of back or alternating buttock pain. Inflammatory features include morning stiffness, night pain that improves on getting up, improvement with exercise and limited relief from rest. Ask about heel or chest-wall pain, swollen joints, sausage digits, recurrent painful photophobic red eye, psoriasis including scalp or nails, chronic diarrhoea, blood in stool, weight loss and family history. Record infection exposure, prior tuberculosis, medicines, pregnancy plans, smoking, work and functional restriction.
Examination
Observe posture and gait, then assess spinal movement with reproducible measures rather than impression alone. Examine cervical rotation, lumbar flexion, lateral flexion, chest expansion and sacroiliac provocation cautiously. Inspect every peripheral joint and enthesis, skin and nails; ask about eye symptoms even when the eye looks normal. Neurological examination is essential when pain radiates, weakness or sensory change exists, or cord and cauda equina disease is possible. Record baseline function and disease activity with validated instruments where services support them.
Investigations
Order C-reactive protein or erythrocyte sedimentation rate, but do not exclude disease when normal. HLA-B27 is useful when pre-test probability is intermediate and its result will change referral or interpretation. Current guidelines recommends sacroiliac-joint radiography in suspected axial disease, followed by MRI using an inflammatory-back-pain protocol when radiography is nondiagnostic and suspicion persists. MRI should assess structural and inflammatory lesions and be interpreted by experienced readers; a negative scan does not always close the case. Full blood count, renal and liver tests establish treatment safety. Evaluate bowel, skin or eye disease with the relevant specialty. Classification criteria support research consistency but do not replace rheumatologist diagnosis.
Differential Diagnosis
Mechanical low-back pain is common and may improve with time, graded activity and rehabilitation, but inflammatory and mechanical features can coexist. Degenerative disc disease, facet arthropathy and osteoarthritis may produce stiffness and imaging abnormalities. Osteitis condensans ilii, postpartum sacroiliac change, athletic mechanical stress and anatomical variants can resemble sacroiliitis on MRI. Diffuse idiopathic skeletal hyperostosis produces flowing spinal ossification without the same sacroiliac inflammatory pattern. Always relate images to age, symptom chronology and objective findings.
Infection must be considered when pain is acute or focal, fever or constitutional symptoms occur, inflammatory markers rise substantially, immune suppression exists or imaging is destructive and asymmetric. Tuberculous spondylitis and bacterial discitis are particularly important in India; biopsy or microbiological confirmation may be needed before immunosuppression. Malignancy, myeloma and metastatic disease can cause night pain and weight loss. Vertebral fracture may follow trauma that appears minor in an ankylosed spine.
Other inflammatory conditions include psoriatic arthritis, reactive arthritis, inflammatory bowel disease-associated spondyloarthritis and undifferentiated peripheral disease; these sit within the wider spondyloarthritis family and influence medicine choice. Rheumatoid arthritis usually has a different peripheral pattern, while fibromyalgia can amplify pain and disease-activity scores without proving ongoing inflammation. Hip osteoarthritis, avascular necrosis and greater trochanteric pain can limit mobility independently. Neurological mimics include radiculopathy, spinal stenosis and cauda equina syndrome. A poor response to an appropriate anti-inflammatory trial should reopen diagnosis, adherence, comorbidity and pain mechanism rather than automatically trigger stronger immunosuppression.
Management
The treatment goal is maximal quality of life through control of symptoms and inflammation, preservation of function and social participation and prevention of structural damage. Explain the diagnosis and uncertainty honestly, support smoking cessation and prescribe regular individualized exercise. Specialist physiotherapy should include spinal mobility, posture, strengthening, aerobic fitness and breathing exercises; group or hydrotherapy options depend on access. Prolonged rest is counterproductive, whereas unsafe high-impact manipulation should be avoided in a rigid or osteoporotic spine.
NSAIDs are first-line pharmacological treatment for pain and stiffness when risks permit, using the lowest effective regimen with toxicity review. Conventional synthetic disease-modifying drugs do not treat purely axial inflammation effectively, although sulfasalazine may be considered for prominent peripheral arthritis. Local glucocorticoid injection can help selected peripheral sites, but direct injection around the Achilles or patellar tendon requires expertise and systemic long-term glucocorticoids are not routine axial therapy.
For persistently active disease despite non-pharmacological care and appropriate NSAID use, rheumatology may initiate a biologic or targeted synthetic DMARD after confirming the diagnosis and considering objective inflammation. Current options include TNF inhibitors, IL-17 inhibitors and JAK inhibitors. Extra-musculoskeletal disease guides selection: monoclonal TNF inhibitors are often preferred for recurrent uveitis or active inflammatory bowel disease, whereas significant psoriasis may favour an IL-17 pathway option; IL-17 blockade can be unsuitable in active IBD. Response is formally assessed and ineffective therapy prompts review of diagnosis, inflammation, adherence and comorbidity before cycling agents.
Prescribing Information
Before an NSAID, assess renal function, blood pressure, gastrointestinal bleeding risk, anticoagulants, asthma sensitivity, pregnancy and cardiovascular disease. Avoid combining multiple NSAIDs. Gastroprotection depends on individual risk and local protocol. Symptom improvement supports continued use but does not confirm diagnosis. Long-term continuous treatment may be reasonable when symptoms recur, yet periodic review should test ongoing need and toxicity. Opioids do not control inflammation and are not a disease-modifying substitute.
Before biologic or JAK-pathway treatment, document active disease and previous therapy, screen for active and latent tuberculosis and hepatitis according to local guidance, review vaccinations and exclude serious infection. Obtain blood count, renal and liver baselines and consider pregnancy, thrombosis, malignancy and cardiovascular risks relevant to the agent. Live vaccines are generally avoided during significant immunosuppression. TNF inhibitors, IL-17 inhibitors and JAK inhibitors have distinct adverse-effect profiles and cannot be interchanged by class name alone. Biosimilar switching requires a regulated product, traceable batch and shared monitoring plan.
Patients should receive written instructions on infection symptoms and withholding or seeking advice during serious illness. Do not begin a biologic from an educational page, and do not give empirical antitubercular therapy solely because a screening assay is positive. Suspected active tuberculosis requires microbiological and imaging assessment through an appropriate service. This guide omits doses and reimbursement thresholds because product licensing, body factors, organ function, public procurement and insurer criteria vary. The current prescription and monitoring protocol of the treating rheumatology service takes precedence.
When to Refer
Current guidelines recommends rheumatology referral for back pain beginning before age 45 and lasting more than three months when multiple spondyloarthritis features are present, with HLA-B27 helping selected borderline pathways. Features include young onset, night waking, buttock pain, improvement with movement or NSAIDs, first-degree family history, arthritis, enthesitis and psoriasis. Referral should also be considered when clinical suspicion remains despite not meeting a simple checklist. Do not exclude axial spondyloarthritis because the patient is female, HLA-B27 negative, has normal inflammatory markers or has a normal radiograph.
Urgent ophthalmology assessment is required for a painful red photophobic eye or sudden visual change because acute anterior uveitis needs slit-lamp diagnosis and prompt treatment. Gastroenterology referral is appropriate for persistent diarrhoea, rectal bleeding, weight loss or suspected inflammatory bowel disease. Dermatology can clarify psoriasis when the phenotype or systemic-treatment choice is uncertain. Orthopaedic or spinal surgical advice may be needed for severe hip destruction, deformity, neurological compression or unstable fracture, while surgery is not routine treatment for uncomplicated inflammatory back pain.
In India, referral notes should include symptom onset, inflammatory features, extra-musculoskeletal disease, examination measures, inflammatory markers, HLA-B27 if obtained, actual images or reports, infection history and previous NSAID dose and duration. State the capability required: rheumatology diagnosis, protocol MRI interpretation, uveitis assessment or biologic safety screening. Patients should not be left without exercise advice, analgesic-risk review and emergency safety-netting while waiting for specialist care.
Red Flags
New weakness, sensory loss, saddle anaesthesia, bladder or bowel dysfunction, gait deterioration or upper-motor-neuron signs suggests cord or cauda equina compromise and requires emergency imaging and specialist assessment. A fused or osteoporotic spine may fracture after a low-energy fall, sometimes with initially subtle pain; immobilization and urgent CT-based evaluation are safer than repeated forceful examination. Sudden severe focal spinal pain, deformity or neurological symptoms after trauma should never be dismissed as an ordinary flare.
Fever, weight loss, marked night sweats, a new focal vertebral tenderness, very high inflammatory markers or constitutional deterioration raises concern for spinal infection, tuberculosis or malignancy. Immunosuppression can blunt fever. Destructive or unilateral sacroiliac imaging, abscess or neurological compression is not the usual symmetrical inflammatory pattern and warrants microbiology and tissue diagnosis where appropriate before advanced immunosuppression. Severe chest pain or breathlessness requires assessment for cardiopulmonary emergencies rather than attribution to chest-wall enthesitis.
A painful photophobic red eye with blurred vision may be anterior uveitis and needs same-day eye care; steroid drops should not be self-started because keratitis and angle closure can mimic it. Treatment red flags include serious infection, jaundice, cytopenia, severe rash, thrombosis or pregnancy during potentially hazardous therapy. New abdominal symptoms on IL-17 inhibition or thrombotic and major cardiovascular symptoms during a JAK inhibitor demand urgent drug-specific review. Safety advice must identify where to attend and which medicines to report, not merely advise follow-up if worse.
Indian Clinical Context
Delayed recognition is plausible where chronic back pain is routinely labelled mechanical and rheumatology or protocol MRI is difficult to access. A high-quality first assessment does not require indiscriminate scanning: establish age at onset, inflammatory features, extra-musculoskeletal manifestations and objective function, then use radiography, HLA-B27 and MRI selectively. Images should be retained for expert review because report wording alone may overcall or miss sacroiliitis. Physiotherapy access and a sustainable home exercise programme matter at every treatment level.
Tuberculosis safety is central before TNF, IL-17 or JAK pathway treatment. India’s National Tuberculosis Elimination Programme and local infectious-disease protocols should guide evaluation and preventive treatment. Screening must look for active disease through symptoms, examination, imaging and microbiology when indicated; an immune-based test cannot by itself separate latent from active tuberculosis. Previous treatment records and drug-resistance context matter. Immunosuppression should not start while unexplained evidence of active infection remains unresolved, but necessary rheumatology care should be coordinated rather than abandoned.
Access to biologics, biosimilars and targeted tablets differs across public schemes, employers, insurers and private payment. A cheaper product is not safer unless procurement, cold chain, traceability and pharmacovigilance are sound. The current guidelines, ASAS-EULAR and BSR sources used here reflect European and UK systems and are not Indian statutory reimbursement rules. NMC competencies describe undergraduate outcomes. Local licensing, hospital formularies, state programmes and specialist judgment prevail. The guide therefore emphasizes transferable diagnostic and safety principles and makes no claim that every recommended agent or MRI pathway is uniformly available.
NMC Competency Mapping
The 2024 NMC orthopaedics curriculum explicitly includes ankylosing spondylitis in OR5.1. That competency asks learners to approach polyarthritis and discuss the aetiopathogenesis, clinical features, investigations and principles of management of inflammatory joint disorders including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. General Medicine Topic 7, GM7.1 through GM7.22, adds autoimmune mechanisms, systematic assessment of joint pain, examination of joints, muscle and skin, diagnostic work-up, treatment planning, disease-modifying therapy, communication, follow-up and specialist consultation.
A learner should recognize inflammatory-pattern back pain, sacroiliac involvement, enthesitis, peripheral arthritis and the links with uveitis, psoriasis and inflammatory bowel disease. They should know that HLA-B27 and C-reactive protein cannot independently confirm or exclude disease, that plain radiography identifies radiographic sacroiliitis and that MRI requires an appropriate protocol and clinical interpretation. Examination teaching should include posture, spinal movement, chest expansion, entheses, peripheral joints, skin, nails and focused neurology.
Management knowledge includes exercise and specialist physiotherapy, safe NSAID use, the limited role of conventional DMARDs in axial disease and the specialist role of biologic or targeted therapy. Safety competencies encompass tuberculosis and hepatitis screening, vaccination, medicine monitoring and urgent recognition of uveitis, spinal fracture, neurological compromise and infection. Actual biologic initiation, MRI interpretation and spinal manipulation require supervised training and local authorization. OR5.1 provides principles, not independent rheumatology prescribing competence; this guide does not certify it.
Key Exam Pearls for NEET PG
Ankylosing spondylitis is radiographic axial spondyloarthritis. It commonly begins before age 45 with inflammatory back pain, alternating buttock pain, morning stiffness and improvement with exercise. Sacroiliitis is central; early plain films can be normal, while MRI may show active inflammation before definite radiographic change. HLA-B27 supports a compatible phenotype but neither its presence nor absence decides the diagnosis. ESR and CRP may be normal. Syndesmophytes classically bridge adjacent vertebrae, and advanced disease can produce a bamboo-spine appearance, but waiting for this sign causes late diagnosis.
Enthesitis often affects the Achilles tendon or plantar fascia. Extra-musculoskeletal associations are acute anterior uveitis, psoriasis and inflammatory bowel disease. A painful photophobic red eye is an urgent ophthalmology problem. Restrictive chest mechanics, hip disease, osteoporosis and aortic-root or conduction disease are recognized complications. A rigid spine is fracture-prone after minor trauma; new focal pain or neurology needs urgent CT assessment. Cauda equina syndrome is a late but serious neurological complication.
Exercise and physiotherapy are foundational. NSAIDs are usual first drug therapy. Conventional synthetic DMARDs do not control purely axial disease, though sulfasalazine may help peripheral arthritis. Active disease despite appropriate first measures may lead to TNF, IL-17 or JAK inhibition under rheumatology care. Recurrent uveitis or active IBD often favours a monoclonal TNF inhibitor, while IL-17 inhibition can be problematic with active IBD. Before advanced therapy in India, actively evaluate tuberculosis and complete agent-specific safety screening.
Frequently Asked Questions
Can ankylosing spondylitis be excluded by a negative HLA-B27 blood test?
No. HLA-B27 changes probability but is not present in every affected person, and many carriers never develop disease. Diagnosis integrates age and pattern of symptoms, extra-musculoskeletal features, examination, inflammatory markers and appropriately interpreted imaging. A negative result must not block rheumatology referral when the clinical picture remains persuasive.
What is the difference between ankylosing spondylitis and non-radiographic axial spondyloarthritis?
Both are within axial spondyloarthritis. Ankylosing spondylitis means definite sacroiliac structural change is visible on plain radiography; non-radiographic disease lacks that finding but may still have clinical and MRI evidence of inflammation. Symptoms and disability can be substantial in either group, and not every non-radiographic case progresses.
Why is daily exercise treated as a core intervention rather than optional advice?
Axial inflammation, pain and guarded movement can progressively reduce spinal mobility, posture, chest expansion and fitness. An individualized programme preserves movement and function alongside medicines. It should be sustainable and guided by a knowledgeable physiotherapist; forceful manipulation is unsafe when the spine is rigid, osteoporotic or possibly fractured.
What must be checked before starting biologic treatment for axial spondyloarthritis in India?
The rheumatology team confirms active disease and previous treatment, excludes serious infection, evaluates active and latent tuberculosis, checks hepatitis risk, blood counts and organ function, reviews vaccinations and discusses pregnancy and agent-specific harms. A positive tuberculosis screening test requires contextual evaluation; it is not permission for self-treatment or proof of active disease.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic